XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D208. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 600 | -25.0% | 0.00% | – |
| Q1 2016 | $1,000 | – | 800 | +700.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 400 | -61.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 1,026 | -10.7% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 1,149 | +56.8% | 0.00% | – |
| Q2 2014 | $2,000 | 0.0% | 733 | +46.6% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 500 | +42.5% | 0.00% | – |
| Q4 2013 | $1,000 | – | 351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|